PD-L1 Expression Associated with Epstein—Barr Virus Status and Patients’ Survival in a Large Cohort of Gastric Cancer Patients in Northern Brazil

SIMPLE SUMMARY: The programmed death ligand 1 (PD-L1) tumor expression is a manifestation of immune evasion and is used as a biomarker for treatment by immunotherapy and appears as a promising therapeutical option for Gastric Cancer (GC). The aim of this study was to evaluate the correlation between...

Descripción completa

Detalles Bibliográficos
Autores principales: de Fátima Aquino Moreira-Nunes, Caroline, de Souza Almeida Titan Martins, Cláudia Nazaré, Feio, Danielle, Lima, Isamu Komatsu, Lamarão, Leticia Martins, de Souza, Carolina Rosal Teixeira, Costa, Igor Brasil, da Silva Maués, Jersey Heitor, Soares, Paulo Cardoso, de Assumpção, Paulo Pimentel, Burbano, Rommel Mário Rodríguez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268941/
https://www.ncbi.nlm.nih.gov/pubmed/34206307
http://dx.doi.org/10.3390/cancers13133107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268941/
https://www.ncbi.nlm.nih.gov/pubmed/34206307
http://dx.doi.org/10.3390/cancers13133107

Ejemplares similares